Skip to main content
. 2024 Sep 19;41:100855. doi: 10.1016/j.bbih.2024.100855

Fig. 5.

Fig. 5

IL-6 and IL-10 levels related to cardiovascular comorbidities in postmortem samples of COVID-19 patients. A. IL-10 levels in the brain/olfactory pathway of patients with and without cardiovascular disease. B. mRNA levels of IL-10 in the brain/olfactory pathway associated with hypertension. C. Correlation analysis of IL-10 mRNA and cardiovascular disease. D. IL-6 mRNA in the brain/olfactory pathway of patients with and without cardiovascular disease. E. Levels of IL-6 in the brain/olfactory pathway associated with hypertension. F. Correlation analysis of IL-6 levels and cardiovascular disease. CD – cardiovascular disease; HTN – hypertension. HTN + - hypertension + cardiovascular and kidney disease. A and D- N = 5 and 11 respectively; B and D- N = 5, 5, 6 respectively. Bar/Dot plots indicate mean ± SEM. ∗ indicates difference from no CD (A-D- Student´s t-test; B and E−one-way ANOVA followed by Duncan´s posttest.